Absence of Factor V Leiden (G1691A) mutation, FII G20210A allele in coronary artery disease in North India

Indian Journal of Medical Sciences

Volumn 57, Issue 12, 2003, Pages 535-542

  Gupta, N ^a   Khan, F ^a   Tripathi, M ^a   Singh, V P ^a   Tewari, S ^a   Ramesh, V ^a   Sinha, N ^a   Agrawal, S ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Coronary artery disease; Factor V Leiden (G1691A) mutation; Prothrombin gene (F IIG20210A) polymorphism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MUTATION; GENETIC POLYMORPHISM; HEART INFARCTION; HEREDITY; HUMAN; INCIDENCE; INDIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PREDICTION; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; FACTOR V; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; POINT MUTATION;

EID: 7244231457     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lane AD, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000;95:1517-32
2. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
3. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999;341:801-6.
4. Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT, et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997;89:2817-21.
5. Mansourati J, Da Costa A, Munier S, Mercier B, Tardy B, Ferec C, et al. Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography. Thromb Haemost 2000;83:822-5.
6. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-7.
7. Cushman M, Rosendaal FR, Psaty BM, Cook EF, Valliere J, Kuller LH, et al. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study. Thromb Haemost 1998;79:912-5.
8. Juul K, Tybjaerg-Hansen A, Steffensen R, Kofoed S, Jensen G, Nordestgaard BG. Factor V Leiden: The Copenhagen City Heart Study and 2 metaanalyses. Blood 2002;100:3-10.
9. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997;90:1747-50.
10. Franco RF, Trip MD, Ten H, van den Ende A, Prins MH, Kastelein JJ, et al. The 20210 G→A mutation in the 3′-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol 1999;104:50-4.
11. Doggen CJ, Cats VM, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998;97:1037-41.
12. Gardemann A, Arsic T, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W. The factor II G20210A and factor V G1691A gene transitions and coronary heart disease. Thromb Haemost 1999;81:208-13.
13. Corral J, Gonzalez-Conejero R, Lozano ML, Rivera J, Heras I, Vicente V. The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. Br J Haematol 1997;99:304-7.
14. Russo C, Girelli D, Olivieri O, Guarini P, Manzato F, Pizzolo F, et al. G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease. Circulation 2001;103:2436-40.
15. Coulet F, Godard V, Verdy E, Soubrier F. Lack of association of the prothrombin gene variant G20210A with myocardial infarction in Caucasian males. Thromb Haemost 2000;83:796-7.
16. Croft SA, Daly ME, Steeds RP, Channer KS, Samani NJ, Hampton KK. The prothrombin 2021OA allele and its association with myocardial infarction. Thromb Haemost 1999;81:861-4.
17. Tanis BC, Bloemenkamp DG, van den Bosch MA, Kemmeren JM, Algra A, van de Graaf Y, et al. Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction. Br J Haematol 2003;122:471-8.
18. Eikelboom JW, Baker RI, Parsons R, Taylor RR, van Bockxmeer FM. No association between the 20210G A prothrombin gene mutation and premature coronary artery disease. Thromb Haemost 1998;80:878-80.
19. Prohaska W, Schmidt M, Mannebach HM, Gleichmann U, Kleesiek K. The prevalence of the prothrombin 20210G→A mutation is not increased in angiographically confirmed coronary artery diaease. Thromb Haemost 1999;81:161-2.
20. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999;99:999-1004.
21. Herrmann FH, Sanchez LS, Schroder W, Grimm R, Schuster G, Arce J, et al. Prevalence of molecular risk factor FV Leiden, FVHR2, FII20210G→A and MTHFR 677C→T in different populations and ethnic groups of Germany, Costarica, and India. Int J Hum Genet 1:33-9.
22. Pawar AR, Shetty S, Ghosh K, Mohanty D. How old is factor V Leiden mutation? Thromb Hemost 2001;86:1591-2
23. Garewal G, Das R, Trehan U. Factor V Leiden: Prevalence in the indigenous population and cases of thrombosis in North India. Br J Haematol 1997;97:940.
24. Garewal G, Das R, Ahluwalia J, Mittal N, Varma S. Prothrombin G20210A is not prevalent in North India. J Thromb Haemost 2003;1:2253-4.
25. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35
26. Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the Factor V Leiden Arg 506 GIn mutation. Blood Coagulation Fibrinolysis 1995;6:245-8.
27. Thakur S, Agarwal S, Khan F, Phadke SR, Pradhan M, Pandey M, et al. Factor V Leiden mutation (G1691A) in women with recurrent spontaneous abortions from North India. Obs Gynae today 2003 (in press).
28. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
29. Zivelin A, Griffin JH, Xu X, Pabinger I, Samama M, Conard J, et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 1997;89:397-402.
30. Zivelin A, Rosenberg N, Faier S, Kornbrot N, Peretz H, Mannhalter C, et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 1998;92:1119-24
31. Amero AKK, Wyngaard CA, Kambouris M, Dzimri N. Prevalence of the 20210G→A prothrombin variant and its association with coronary artery diseasein a middle eastern Arab population. Arch Pathol Lab Med 2002;126:1087-90.